Results 241 to 250 of about 168,994,423 (308)

Reply. [PDF]

open access: yesACR Open Rheumatol
Hospach T, Wong W, Hedrich CM.
europepmc   +1 more source

Machine Learning to Predict Remission Between 6 and 24 Months in Rheumatoid Arthritis: Insights From JAK, an International Registry Collaboration

open access: yesArthritis &Rheumatology, EarlyView.
Objective To develop, externally validate, and simplify a machine learning model to predict remission between 6 and 24 months in patients with rheumatoid arthritis (RA) initiating tumor necrosis factor inhibitors, JAK inhibitors, interleukin‐6 inhibitors, abatacept, or rituximab using data from 11 international registries in the JAK‐pot collaboration ...
Zubeyir Salis   +22 more
wiley   +1 more source

Harmonising the scope of practice for genetic counsellors in the D-A-CH region: a cross-border consensus for Germany, Austria, and Switzerland. [PDF]

open access: yesEur J Hum Genet
Schwaninger G   +7 more
europepmc   +1 more source

Austrian Society of Gastroenterology and Hepatology (ÖGGH) consensus on primary biliary cholangitis. [PDF]

open access: yesWien Klin Wochenschr
Halilbasic E   +18 more
europepmc   +1 more source

Triple A syndrome with a new mutation pattern, first documented case in Austria: a case report with literature review. [PDF]

open access: yesOrphanet J Rare Dis
Anderle K   +8 more
europepmc   +1 more source

The history and evolution of radiotherapy and radiation oncology in Austria

International Journal of Radiation Oncology Biology Physics, 1996
Austria has a longstanding and eventful history in the field of radiotherapy and radiation oncology. The founder of radiotherapy, Leopold Freund, began his well-documented first therapeutic irradiation on November 24, 1896, in Vienna. He also wrote the first textbook of radiotherapy in 1903.
exaly   +3 more sources

Home - About - Disclaimer - Privacy